Literature DB >> 1001221

A new look at the use of ergotamine.

J M Bradfield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001221     DOI: 10.2165/00003495-197612060-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  3 in total

1.  Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

Authors:  V Ala-Hurula; V V Myllylä; P Arvela; N T Kärki; E Hokkanen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

2.  Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.

Authors:  V Ala-Hurula
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Authors:  V L Perrin
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.